These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8627472)

  • 1. Growth hormone deficiency in adults: characteristics and response to growth hormone replacement.
    Lieberman SA; Hoffman AR
    J Pediatr; 1996 May; 128(5 Pt 2):S58-60. PubMed ID: 8627472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects.
    Amato G; Izzo G; La Montagna G; Bellastella A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):27-32. PubMed ID: 8796135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone replacement therapy for growth hormone-deficient adults.
    Powrie J; Weissberger A; Sönksen P
    Drugs; 1995 May; 49(5):656-63. PubMed ID: 7601008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone treatment for growth hormone deficient adults.
    Clark W; Kendall MJ
    J Clin Pharm Ther; 1996 Dec; 21(6):367-72. PubMed ID: 9201562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C; Johannsson G; Bengtsson BA; Svensson J
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
    Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
    Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Growth hormone deficiency in adults--clinical picture and treatment].
    Christiansen JS; Jørgensen JO; Müller JR; Skakkebaek NE
    Ugeskr Laeger; 1995 Jan; 157(4):428-32. PubMed ID: 7846786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult growth hormone deficiency.
    Jørgensen JO; Müller J; Møller J; Wolthers T; Vahl N; Juul A; Skakkebaek NE; Christiansen JS
    Horm Res; 1994; 42(4-5):235-41. PubMed ID: 7868079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher plasma somatomedin A (biological) and C (immunological) levels with sc than with im growth hormone replacement therapy.
    Christiansen JS; Kastrup KW; Alberti KG; Petersen KE; Christiansen C; Orskov H
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):169-72. PubMed ID: 3893007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone therapy for adult growth hormone deficiency.
    Shalet SM
    Int J Clin Pract; 1998 Mar; 52(2):108-11. PubMed ID: 9624793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses.
    Amato G; Carella C; Fazio S; La Montagna G; Cittadini A; Sabatini D; Marciano-Mone C; Saccá L; Bellastella A
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1671-6. PubMed ID: 8263158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone therapy of short stature.
    Knudtzon J
    Acta Paediatr Scand; 1986 May; 75(3):353-61. PubMed ID: 3088905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone and changes in energy balance in growth hormone deficient adults.
    Deepak D; Daousi C; Boyland E; Pinkney JH; Wilding JP; MacFarlane IA
    Eur J Clin Invest; 2008 Sep; 38(9):622-7. PubMed ID: 18837737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone deficiency in adults and its response to growth hormone replacement.
    Labram EK; Wilkin TJ
    QJM; 1995 Jun; 88(6):391-9. PubMed ID: 7648230
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper.
    Rosén T; Johannsson G; Johansson JO; Bengtsson BA
    Horm Res; 1995; 43(1-3):93-9. PubMed ID: 7721271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to Growth Hormone, Standardization of IGF-I Measurements. Proceedings of the 5th KIGS/KIMS Expert Meeting on Growth and Growth Disorders. Windsor, United Kingdom. February 2-3, 2001.
    Horm Res; 2001; 55 Suppl 2():1-110. PubMed ID: 11775586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.